Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

NIH Grants & Funding for Brain Glioblastoma | Kisho | Kisho

Back to Brain Glioblastoma

Brain Glioblastoma — NIH Grants & Funding

Active and recent NIH-funded research on Brain Glioblastoma. Data from NIH RePORTER, last 36 months.

MONDO:0002501

NIH-funded research on Brain Glioblastoma

active grants

institutions

researchers

new in last 12 mo.

$18.3M in NIH funding over the last 36 months. Data from NIH RePORTER.

I'm looking for:

Or filter by research focus

Only show active grants

Basic Science(9)

Basic ScienceR01Active

Quantitative imaging and molecular data modeling for brain tumor recurrence and progression analysis

Iftekharuddin, Khan·OLD DOMINION UNIVERSITY·NORFOLK, VA

$634,465 (FY2025)

Brain Glioblastoma — NIH Grants & Funding

Basic Science(9)

Quantitative imaging and molecular data modeling for brain tumor recurrence and progression analysis

Deciphering TREM1/2 Function in Primary Brain Cancer Using a New Model of Glioblastoma

GLIOMA INTERACTION WITH THE NEUROGENIC NICHE THROUGH EXTRACELLULAR VESICLES

Boosting IL-12-induced anti-glioblastoma activity via immunotherapeutic extracellular vesicles.

Defining and interrupting metabolic crosstalk in the glioblastoma microenvironment

Spatial and Clonal Dynamics in Glioblastoma: Disentangling Drivers of Migration and Stemness

Aberrant activation of epidermal growth factor receptor signaling drives programming of an immunosuppressive brain tumor microenvironment in glioblastoma

Novel relationships of splicing factors in temozolomide-resistant glioblastoma

Targeting brain tumor initiating cell-specific super-enhancer associated genes to treat glioblastoma

Translational(7)

Developing a Clinically Relevant Radiosensitizer for Temozolomide-resistant Gliomas

Targeted drug delivery system to overcome blood-brain barrier and therapeutic resistance to current standard of care in Glioblastoma

Nanocage-based systemic delivery of TGFb trap for immunomodulation of brain neoplasms

Radiation-induced senescence in the brain microenvironment: Implications for glioblastoma recurrence and therapy

Targeting glioblastoma with CM93, a novel EGFR inhibitor with exceptional brain penetration

New anti-glioblastoma metabolic compounds with high potential for Blood Brain Barrier penetration

Targeting ATG4B to Treat Glioblastoma

Clinical(5)

Whole-brain Spectroscopy Guided Personalized Mapping of Transducer Arrays for Glioblastoma Patients Receiving Tumor Treating Fields

Blood-brain barrier disruption with implantable ultrasound to enhance paclitaxel delivery: A Phase 1-2 clinical trial in recurrent glioblastoma

IDO1 and Immunotolerance in Glioblastoma

Determining the optimal ion and fractionation scheme for the treatment of GBM in a comprehensive human organoid model

Harnessing Tumor Associated Macrophages in Glioblastoma

Epi / Nat. History(1)

Oncolytic Virus Therapeutic Responses Occur from Changes in the Glioblastoma Immune Microenvironment

Gene/Cell Therapy(2)

CAR neutrophils produced in vivo to remodel tumor microenvironment and treat glioblastoma

Novel approaches to enrich CAR-T cell Therapy in brain tumors using focused ultrasound

Biomarker / Dx(1)

A Novel Imaging Strategy to Optimize Brain Tumor Immunotherapy